NASDAQ$ATEC

Alphatec Holdings Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

ATEC reported Q3 2021 financial results with a revenue increase driven by the adoption of the PTP technique and EOS imaging.

Alphatec Holdings, Inc. reported a strong third quarter with a 53% increase in total revenue, driven by organic growth and the adoption of the PTP technique. Revenue related to EOS imaging exceeded $11 million. The company is increasing its full year revenue guidance to $235 million.

  • Total revenue grew by 53%, including 29% organic revenue growth.
  • ATEC lateral delivered over 50% of Q3 revenue growth driven by advancing adoption of PTP Technique.
  • EOS imaging revenue exceeded $11 million.
  • Surgeon users expanded by 20% compared to Q3 2020.

Headline financials

Total Revenue

$62.9M

Previous: $41.2M+52.8%
EPS (adj)

-$0.36

Previous: -$0.24-50.0%
Non-GAAP Gross Margin

72.0%

No prior period
Capital Expenditures

-$48.9M

Previous: -$12.9M-280.4%
Free Cash Flow

-$92M

Previous: -$28.5M-222.3%
Net Income

-$43M

Previous: -$15.7M-174.6%
Operating Income

-$35.1M

Previous: -$12.9M-173.1%
Gross Profit

$39.6M

Previous: $29.2M+35.5%
Cash & Equivalents

$224M

Previous: $15.7M+1327.9%
Total Assets

$598M

Previous: $155M+286.7%
Stock-Based Comp

$10.8M

No prior period

Revenue & EPS history

Alphatec · Revenue · Quarterly

$62.9M

Q3 2021+52.8%vs Q3 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Alphatec · $104M total across 1 segment · Q3 2023

  • Surgical Revenue
    $104M

Forward guidance

The Company now expects total revenue for the fiscal year ended December 31, 2021, to approximate $235 million, reflecting growth of approximately 62% compared to the prior full year. This includes an organic revenue contribution of approximately $208 million, or 47% growth compared to the prior full year, which has been updated to reflect the impact of the COVID pandemic in the third quarter 2021. The Company now anticipates about $26 million of revenue related to EOS imaging, which accounts for slightly stronger than expected EOS-related revenue in the third quarter 2021. Total revenue guidance for the full year also includes an approximate $1 million contribution from the Company’s international supply agreement, which terminated on August 31, 2021.

Tailwinds

  • Total revenue for 2021 is expected to be approximately $235 million.
  • Reflecting growth of approximately 62% compared to the prior full year.
  • Organic revenue contribution of approximately $208 million.
  • Organic revenue growth of 47% compared to the prior full year.
  • Approximately $26 million of revenue related to EOS imaging.

Headwinds

  • Revenue guidance has been updated to reflect the impact of the COVID pandemic in the third quarter 2021.
  • International supply agreement terminated on August 31, 2021, including an approximate $1 million contribution.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-1.5%

Avg return

Earnings day

-1.4%

Avg return

5 days after

-0.1%

Avg return

30 days after

45%

29 / 64 earnings

Positive

+44.8%

Q3 2024

Best reaction

-43.2%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.9%-27.1%-23.3%
Q4 2025+0.5%-3.3%-21.5%
Q3 2025-0.8%+17.8%+36.7%
Q1 2025+2.4%+2.2%+2.2%
Q4 2024+9.6%+6.1%-7.9%
Q3 2024+44.8%+54.2%+93.4%
Q2 2024-32.8%-33.7%-30.2%
Q1 2024-20.2%-13.3%-22.7%
Q4 2023-7.4%-11.1%-8.6%
Q3 2023+4.7%-1.5%+20.8%
Q2 2023-7.1%-10.4%-5.2%
Q1 2023+3.1%+3.8%+4.5%
Q4 2022+1.6%+7.9%+6.3%
Q3 2022-1.5%-1.4%+9.5%
Q2 2022-0.2%-3.8%-10.9%
Q1 2022-16.1%-27.7%-34.0%
Q4 2021+3.1%+3.4%+4.4%
Q3 2021-2.2%-8.2%-18.7%
Q2 2021+2.4%-5.8%-0.2%
Q1 2021-2.0%-9.1%-8.3%
Q4 2020-7.6%+4.2%-2.1%
Q3 2020+9.4%+4.7%+22.1%
Q2 2020+21.8%+5.6%+3.1%
Q1 2020-8.0%-13.9%+5.7%
Q4 2019-8.4%-20.8%-47.2%
Q3 2019+15.2%+16.1%+18.1%
Q2 2019+9.3%+8.5%+26.2%
Q1 2019+5.4%+15.8%+8.8%
Q4 2018+14.7%+16.6%+22.1%
Q3 2018-1.7%-5.6%-13.5%
Q2 2018+4.7%+15.0%+28.1%
Q1 2018-2.0%-0.9%-1.1%
Q4 2017+0.9%-5.0%+1.2%
Q3 2017-0.8%-0.6%-30.5%
Q2 2017+2.4%+2.4%+40.2%
Q1 2017+1.9%+0.0%-4.8%
Q4 2016-16.0%-27.0%-45.8%
Q3 2016-15.8%-8.0%-12.8%
Q2 2016+2.5%+0.0%-6.5%
Q1 2016-11.8%
Q4 2015-13.8%
Q3 2015+5.8%
Q2 2015-42.6%
Q1 2015+1.4%
Q4 2014+7.4%
Q3 2014-0.7%
Q2 2014+0.0%
Q1 2014+2.3%
Q4 2013+22.3%
Q3 2013-0.5%
Q2 2013-3.9%
Q1 2013-3.2%
Q4 2012+2.6%
Q3 2012-1.8%
Q2 2012-2.5%
Q1 2012-7.4%
Q4 2011-0.5%
Q3 2011-5.6%
Q2 2011-10.4%
Q1 2011+3.7%
Q4 2010+0.4%
Q3 2010-9.6%
Q2 2010-43.2%
Q1 2010+6.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro